NCT06357182
- Conditions
- Acute Myeloid Leukemia, Bone Marrow Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +11 more
- Locations
-
- OHSU Knight Cancer Institute Portland, Oregon, United States
Clinical trial condition
Myelodysplastic Syndrome/Acute Myeloid Leukemia
Explore clinical trials studying Myelodysplastic Syndrome/Acute Myeloid Leukemia. Study availability and eligibility vary by location and protocol.
5 public trials
3 recruiting studies
Myelodysplastic Syndrome/Acute Myeloid Leukemia trial results
NCT06484062
- Conditions
- Acute Myeloid Leukemia, Bone Marrow Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +18 more
- Locations
-
- Yale University New Haven, Connecticut, United States
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
- UC Comprehensive Cancer Center at Silver Cross New Lenox, Illinois, United States
NCT03779854
- Conditions
- Acute Biphenotypic Leukemia, Acute Leukemia, Acute Leukemia of Ambiguous Lineage, +54 more
- Locations
-
- Children's Hospital of Los Angeles Los Angeles, California, United States
- Children's National Medical Center Washington D.C., District of Columbia, United States
- Children's Healthcare of Atlanta Atlanta, Georgia, United States
- University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
NCT03092674
- Conditions
- Acute Myeloid Leukemia, Bone Marrow Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more
- Locations
-
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
- Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
- Alaska Women's Cancer Care Anchorage, Alaska, United States
Active, Not Recruiting
Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
NCT01522976
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +24 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Banner University Medical Center - Tucson Tucson, Arizona, United States